XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
SCHEDULE OF DISAGGREGATED REVENUE

For the three months ended March 31, 2025 and 2024, the Company had the following disaggregated revenue:

 

   Three Months Ended March 31, 
   2025   %   2024   % 
Telehealth subscription revenue  $30,089,964    46%  $7,607,788    17%
Telehealth product revenue   22,366,517    34%   21,264,864    48%
WorkSimpli revenue   13,241,275    20%   13,302,862    30%
Medifast collaboration revenue   -    -%   1,968,750    5%
Total revenues, net  $65,697,756    100%  $44,144,264    100%
SCHEDULE OF CONTRACT WITH CUSTOMER LIABILITY

The following table summarizes deferred revenue activities for the periods presented:

 

   2025   2024 
   Three Months Ended March 31, 
   2025   2024 
Beginning of period  $14,480,917   $8,828,598 
Additions   64,668,542    17,773,373 
Revenue recognized   (64,523,557)   (13,399,214)
End of period  $14,625,902   $13,202,757 
SCHEDULE OF ACCOUNTS RECEIVABLE

The Company’s accounts receivable balances are as follows for each of the periods presented:

 

   March 31,   December 31, 
   2025   2024 
Beginning of period  $8,217,813   $5,277,250 
End of period  $10,192,774   $8,217,813 
SUMMARY OF INVENTORY

As of March 31, 2025 and December 31, 2024, the Company’s inventory consisted of the following:

 

   March 31,   December 31, 
   2025   2024 
Finished goods  $2,212,683   $1,554,600 
Raw materials and packaging components   908,478    1,506,078 
Inventory reserve   (153,464)   (263,320)
Total inventory, net  $2,967,697   $2,797,358